NCT04010305 Sub-Lingual Dexmedetomidine in Agitation Associated With Schizophrenia Status COMPLETED Phase PHASE1
NCT04005794 Virtual Reality Training for Social Skills in Schizophrenia - Comparison With Cognitive Training Status COMPLETED Phase NA
NCT04004416 Multi-modal Assessment of Gamma-aminobutyric Acid (GABA) Function in Psychosis Status COMPLETED Phase PHASE4
NCT04002258 Prolactin Change in Chinese Patients With Schizophrenia After Antipsychotics Treatment Status COMPLETED Phase N/A
NCT03999112 Effect of Metacognitive Therapy on Negative Symptoms: a Case Series Status UNKNOWN Phase NA
NCT03978832 Safety, Tolerability, Pharmacokinetics and Efficacy of 180 mg Subcutaneous Risperidone From 6 mg Oral Risperidone Status COMPLETED Phase PHASE4
NCT03975400 Using Digital Media Advertising to Reduce the Duration of Untreated Psychosis Status COMPLETED Phase NA
NCT03974620 Individual Placement and Support and/or Cognitive Remediation Therapy Added to TAU in Patients With Early Schizophrenia Status NOT_YET_RECRUITING Phase NA
NCT03973853 How Can a Driving Virtual Reality Tool Improve Quality of Life and Social Autonomy in Patients With Schizophrenia Status WITHDRAWN Phase NA
NCT03967431 Effects of Narrative Enhancement and Cognitive Therapy (NECT) on Self-stigma in Patients With Schizophrenia Status COMPLETED Phase NA
NCT03965598 Study on Predictiors and Mechanism of Conversion to Psychosis in Individuals at Ultra-high Risk Group Status UNKNOWN Phase N/A